Verified email-pattern data for Occical Therapeutics is currently limited. You can still use the company insights and contact sections below.
OcciCal Therapeutics est une start-up de biotechnologie basée en Occitanie, spécialisée dans le développement du premier traitement préventif contre la dysfonction diaphragmatique induite par la ventilation mécanique (VIDD), une pathologie méconnue mais d’une incidence significative. Chaque année, plus de 20 millions de patients sous assistance respiratoire sont à risque de développer cette dysfonction, qui altère gravement le pronostic vital et fonctionnel à long terme.
Notre programme de recherche repose sur les découvertes réalisées par le laboratoire PhyMedExp (INSERM-CNRS) et l’IBMM (CNRS), en collaboration avec l’Université de Montpellier et le CHU de Montpellier. Ce projet de R&D explore les mécanismes moléculaires et cellulaires sous-jacents à la VIDD, avec pour objectif de développer une approche thérapeutique innovante fondée sur l’utilisation d’oxylipines. Ces travaux visent à améliorer la gestion clinique des patients ventilés et à réduire la morbidité associée à la ventilation mécanique prolongée.
***
OcciCal Therapeutics is a biotechnology start-up based in Occitanie, specializing in the development of the first preventive treatment for ventilator-induced diaphragm dysfunction (VIDD), a little-known condition with a significant incidence. Each year, more than 20 million patients on respiratory support are at risk of developing this dysfunction, which severely impacts both long-term survival and functional prognosis.
Our research program is built on discoveries made by the PhyMedExp laboratory (INSERM-CNRS) and IBMM (CNRS), in collaboration with the University of Montpellier and Montpellier University Hospital. This R&D project investigates the molecular and cellular mechanisms underlying VIDD, aiming to develop an innovative therapeutic approach based on the use of oxylipins. The goal is to improve the clinical management of ventilated patients and reduce the morbidity associated with prolonged mechanical ventilation.
Company Details
- Employees
- 5
- Founded
- -
- Industry
- Biotechnology Research
- Keywords
- des patients et de la recherche..
Occical Therapeutics Questions
OcciCal Therapeutics's LinkedIn profile is https://www.linkedin.com/company/occical-therapeutics
OcciCal Therapeutics has
5 employees.
View email and phone details for 5
employees at OcciCal Therapeutics.
OcciCal Therapeutics's industry is
Biotechnology Research
OcciCal Therapeutics's top competitors are
Terratis,
Up Review,
Bonjour Basile,
Cilcare,
Floatee,
Shaarp,
Ciloa Sas,
Biodol Therapeutics,
Koovea,
Aporepair.
OcciCal Therapeutics's categories are Biotechnology Research
OcciCal Therapeutics's founding year is 2024
Explore related pages
Related company profiles:
Companies like OcciCal Therapeutics
Top OcciCal Therapeutics Employees
-
Nicolas Kepel
n/a
Rabat, Rabat-Salé-Kénitra, Morocco, Morocco1addequatio.com -
-
Jean-Yves Le Guennec
Professeur Des Universités Chez Université De Montpellier Co-Cso
Montpellier, Occitanie, France, France -
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.